QIAGEN N.V. Expands AI Bioinformatics With New Platforms
QIAGEN N.V. announced AI additions to Ingenuity Pathway Analysis via IPA Investigator and launched the QIAGEN Discovery Platform to extend AI into automated drug discovery workflows.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.